Neurocrine Biosciences
NBIX
NBIX
391 hedge funds and large institutions have $9.56B invested in Neurocrine Biosciences in 2019 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 137 increasing their positions, 103 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
391
Holders Change
+59
Holders Change %
+17.77%
% of All Funds
7.72%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
109
Increased
137
Reduced
103
Closed
41
Calls
$93.9M
Puts
$56.8M
Net Calls
+$37.1M
Net Calls Change
+$33.9M
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$79.5M |
| 2 |
2
BlackRock
New York
|
$709M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$264M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$784M |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$36.6M |
